SMTINasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Sanara MedTech Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$33.14−0.02 (-0.06%)
Close on Oct 19, 2026
- Market cap
- $287.08M
- P/E (TTM)
- –
- Dividend yield
- –
Sanara MedTech Inc. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanara Surgical [Member] | – | – | – | – | $97.22M | $91.57M | $86.67M | $78.06M | $72.41M | $68.00M | $64.99M | – | – | – |
| THP [Member] | – | – | – | – | – | – | – | – | – | – | $2.73K | – | – | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Soft Tissue Repair Products [Member] | $98.34M | $95.76M | $91.35M | $90.16M | $85.60M | $80.58M | $76.13M | $67.67M | $62.44M | $58.05M | $54.84M | $53.11M | 89.5% | +14.9% |
| Bone Fusion Products [Member] | $11.48M | $11.72M | $11.77M | $11.72M | $11.62M | $10.99M | $10.55M | $10.34M | $9.87M | $9.81M | $9.95M | $9.30M | 10.5% | -1.2% |
| Royalty [Member] | – | – | – | – | – | – | – | – | – | – | $201.00K | $201.00K | – | – |
By region
From the segment and revenue-disaggregation notes of Sanara MedTech's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.